Who owns ALIGOS THERAPEUTICS INC?
- Ticker: ALGS
- CUSIP Number: 01626l105
Tip: Access positions for across all investors
Analyze quarterly positions in Aligos Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aligos Therapeutics stock
Who bought or sold ALIGOS THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Armistice Capital | 6.9M | $6.8M | 100% | Mar 2024 |
|
| EcoR1 Capital | 6.4M | $6.3M | 0% | Mar 2024 |
|
| Alyeska Investment Group | 6.1M | $6.0M | -32% | Mar 2024 |
|
| Vivo Capital | 3.5M | $3.5M | 0% | Mar 2024 |
|
| Altitude Crest Partners | 2.8M | $1.9M | 100% | Dec 2023 |
|
| Adage Capital Partners GP | 2.5M | $2.4M | 101% | Mar 2024 |
|
| Versant Venture Management | 2.3M | $2.3M | 0% | Mar 2024 |
|
| Baker Bros. Advisors | 2.1M | $2.0M | 0% | Mar 2024 |
|
| Hillhouse Capital Advisors | 1.9M | $1.3M | -17% | Dec 2023 |
|
| Tang Capital Management | 1.7M | $1.6M | -25% | Mar 2024 |
|
| Opaleye Management | 1.6M | $1.6M | 26% | Mar 2024 |
|
| Newtyn Management | 1.2M | $1.2M | -4% | Mar 2024 |
|
| Bank of America Corporation | 1.1M | $1.1M | 0% | Mar 2024 |
|
| Vanguard Group | 1.0M | $993k | 0% | Mar 2024 |
|
| Acadian Asset Management | 658k | $644k | 17% | Mar 2024 |
|
| UBS O'Connor | 500k | $490k | 100% | Mar 2024 |
|
| Geode Capital Management | 373k | $366k | 54% | Mar 2024 |
|
| BlackRock | 304k | $298k | 2% | Mar 2024 |
|
| Citadel Advisors | 290k | $284k | 100% | Mar 2024 |
|
| Millennium Management | 111k | $108k | 286% | Mar 2024 |
|
| Northern Trust | 92k | $90k | 134% | Mar 2024 |
|
| Bridgeway Capital Management | 92k | $90k | 0% | Mar 2024 |
|
| XTX Topco | 45k | $44k | 100% | Mar 2024 |
|
| Charles Schwab Investment Management | 31k | $31k | 0% | Mar 2024 |
|
| Choate Investment Advisors | 24k | $24k | 0% | Mar 2024 |
|
| Procyon Private Wealth Partners | 20k | $20k | 100% | Mar 2024 |
|
| Two Sigma Investments | 19k | $18k | 0% | Mar 2024 |
|
| CWM | 17k | $17k | 0% | Mar 2024 |
|
| Creative Planning | 16k | $15k | 54% | Mar 2024 |
|
| ZWJ Investment Counsel | 15k | $14k | 100% | Mar 2024 |
|
| Zullo Investment Group | 13k | $13k | 0% | Mar 2024 |
|
| Vontobel Holding | 13k | $12k | 100% | Mar 2024 |
|
| UBS Group | 11k | $11k | 100% | Mar 2024 |
|
| Total Clarity Wealth Management | 10k | $9.8k | 100% | Mar 2024 |
|
| Financial Advocates Investment Management | 10k | $9.8k | 100% | Mar 2024 |
|
| Tower Research Capital | 8.0k | $7.9k | 100% | Mar 2024 |
|
| Morgan Stanley | 3.3k | $3.2k | 65% | Mar 2024 |
|
| Simplex Trading | 1.1k | $1.0k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 677.00 | $662.986100 | 0% | Mar 2024 |
|
| Wells Fargo & Company | 298.00 | $292.010200 | 2% | Mar 2024 |
|
| Royal Bank of Canada | 124.00 | $0 | -72% | Mar 2024 |
|
| Zrc Wealth Management | 100.00 | $98.000000 | 0% | Mar 2024 |
|
| Qube Research & Technologies | 2.00 | $2.000000 | 0% | Mar 2024 |
|
Who sold out of Aligos Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Securities | Dec 2023 | 15k | $9.8k |
| FMR | Sep 2023 | 1.2k | $896.040000 |
| Federated Investors | Sep 2023 | 653.00 | $487.986900 |